FDA 483 - Hitachi High-Technologies Corp., Omuta Center - February 28, 2019

During an inspection of Hitachi High-Technologies Corp.'s Omuta Center in Japan, the FDA observed two significant issues. The firm failed to maintain the acceptance status of products and lacked adequate procedures to prevent contamination in its manufacturing clean room. These conditions indicate deficiencies in quality control and environmental monitoring.